Chemed (CHE) vs Ensign Group (ENSG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Chemed (CHE) has outperformed Ensign Group (ENSG) over the past year, gaining 14.6% versus a loss of 2.8%. Over five years, ENSG leads with a +135.4% price change compared with +15.8% for CHE. Ensign Group is the larger company by market cap ($9.99 billion vs $6.51 billion), about 1.5 times the size.
On valuation, Chemed trades at a lower forward P/E (18.1x vs 20.0x for Ensign Group). Chemed offers the higher dividend yield (0.48% vs 0.15%). Chemed converts more of its revenue into profit, with a net margin of 10.5% versus 6.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CHE | ENSG |
|---|---|---|
| Share price | $498.25 | $171.49 |
| Market cap | $6.51B | $9.99B |
| 1-day change | -0.64% | +1.34% |
| YTD return | +16.45% | -1.56% |
| 1-year return | +14.55% | -2.76% |
| 5-year return | +15.84% | +135.43% |
| P/E ratio (TTM) | 25.06 | 26.88 |
| Forward P/E | 18.11 | 20.04 |
| EPS (TTM) | $19.88 | $6.38 |
| Dividend yield | 0.48% | 0.15% |
| Annual dividend | $2.40 | $0.258 |
| Revenue (latest FY) | $2.53B | $5.06B |
| Revenue growth (YoY) | +4.06% | +18.72% |
| Net income (latest FY) | $265.24M | $343.97M |
| Gross margin | 32.54% | 20.54% |
| Operating margin | 13.37% | 8.41% |
| Net margin | 10.48% | 6.80% |
| 52-week high | $557.00 | $218.00 |
| 52-week low | $365.21 | $141.58 |
| Distance from 52-week high | -10.55% | -21.33% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +14.72% | +28.29% |
| Average volume | 159.85K | 375.95K |
| Shares outstanding | 13.07M | 58.28M |
| Employees | 15,811 | 46,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Hospital/Nursing Management |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CHE has outperformed ENSG by 17.3 percentage points over the past year.
- Ensign Group grew revenue faster in its latest fiscal year (+18.72% vs +4.06%).
About Chemed
CHE stock →Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments.
Health Care · Medical/Nursing Services · 15,811 employees
About Ensign Group
ENSG stock →The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services.
Health Care · Hospital/Nursing Management · 46,000 employees
CHE vs ENSG FAQ
Which is bigger, Chemed or Ensign Group?
Ensign Group (ENSG) is larger, with a market capitalization of $9.99B compared with $6.51B for Chemed (CHE).
Which stock has performed better over the past year, CHE or ENSG?
CHE returned +14.55% over the past 12 months, compared with -2.76% for ENSG (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CHE or ENSG?
CHE has the lower trailing P/E at 25.1, versus 26.9 for ENSG. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Chemed or Ensign Group?
Chemed has the higher yield at 0.48%, compared with 0.15% for Ensign Group.
Are Chemed and Ensign Group in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Nursing Services for Chemed and Hospital/Nursing Management for Ensign Group.